Search

Your search keyword '"Trexler M"' showing total 191 results

Search Constraints

Start Over You searched for: Author "Trexler M" Remove constraint Author: "Trexler M"
191 results on '"Trexler M"'

Search Results

151. K153R polymorphism in myostatin gene increases the rate of promyostatin activation by furin.

152. Emerging technology: applications of Raman spectroscopy for prostate cancer.

153. Banded structures in collagen vitrigels for corneal injury repair.

154. Free-volume hole relaxation in molecularly oriented glassy polymers.

155. Both LCCL-domains of human CRISPLD2 have high affinity for lipid A.

156. Latent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2.

157. Synthesis and properties of regenerated cellulose-based hydrogels with high strength and transparency for potential use as an ocular bandage.

158. A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.

159. Verification and implementation of a modified split Hopkinson pressure bar technique for characterizing biological tissue and soft biosimulant materials under dynamic shear loading.

160. Biological functions of the WAP domain-containing multidomain proteins WFIKKN1 and WFIKKN2.

162. Reassessing domain architecture evolution of metazoan proteins: major impact of gene prediction errors.

163. WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity.

164. The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens.

165. NMR solution structure of the neurotrypsin Kringle domain.

166. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11.

167. Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema.

168. Second Kunitz-type protease inhibitor domain of the human WFIKKN1 protein.

169. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.

170. Gene Symbol: COCH. Disease: DFNA9.

171. NMR structure of the netrin-like domain (NTR) of human type I procollagen C-proteinase enhancer defines structural consensus of NTR domains and assesses potential proteinase inhibitory activity and ligand binding.

172. Expression, purification and characterization of the second Kunitz-type protease inhibitor domain of the human WFIKKN protein.

173. Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2).

174. Expression and characterization of the olfactomedin domain of human myocilin.

175. Structural characterization of the second TSP1-module of human thrombospondin.

176. Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules.

177. Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles.

178. NMR structure of the LCCL domain and implications for DFNA9 deafness disorder.

179. Localization of disulfide bonds in the frizzled module of Ror1 receptor tyrosine kinase.

180. A human protein containing multiple types of protease-inhibitory modules.

181. Worldwide DNA sequence variation in a 10-kilobase noncoding region on human chromosome 22.

182. The LCCL module.

183. Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream.

184. Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain.

185. Sequence-specific 1H NMR assignments and structural characterization of bovine seminal fluid protein PDC-109 domain b.

186. The collagen-binding site of type-II units of bovine seminal fluid protein PDC-109 and fibronectin.

187. PHENOTYPIC PLASTICITY IN THE SAILFIN MOLLY, POECILIA LATIPINNA (PISCES: POECILIIDAE). II. LABORATORY EXPERIMENT.

189. Residues Cys-1 and Cys-79 are not essential for refolding of reduced-denatured kringle 4 fragment of human plasminogen.

190. Analysis and identification of aromatic signals in the proton magnetic resonance spectrum of the kringle 4 fragment from human plasminogen.

191. Chemical modification and nuclear magnetic resonance studies on human plasminogen kringle 4. Assignment of tyrosine and histidine resonances to specific residues in the sequence.

Catalog

Books, media, physical & digital resources